We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+24.59%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.9B
AUM Growth
+$12.2B
(+25%)
Cap. Flow
+$2B
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
3,213
New
281
Increased
1,628
Reduced
1,147
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$134M |
| 2 |
Microsoft
MSFT
|
+$119M |
| 3 |
Apple
AAPL
|
+$87.6M |
| 4 |
AbbVie
ABBV
|
+$61.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$92.9M |
| 2 |
RTN
Raytheon Company
RTN
|
+$71.6M |
| 3 |
CY
Cypress Semiconductor
CY
|
+$23.6M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$12.9M |
| 5 |
Domino's
DPZ
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.43% |
| 2 | Healthcare | 14.28% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Communication Services | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Tandem Diabetes Care
TNDM
$1.5B
| $6.83M | 0.01% |
69,094
-11,904
| -15% | -$950K |
|
|
QTS
1002
DELISTED
QTS REALTY TRUST, INC.
QTS
| $6.82M | 0.01% |
106,367
+17,189
| +19% | +$1.08M |
|
1003
Silgan Holdings
SLGN
$4.44B
| $6.81M | 0.01% |
210,331
+2,245
| +1% | +$73.1K |
|
1004
Dick's Sporting Goods
DKS
$18.5B
| $6.79M | 0.01% |
164,533
-663
| -0.4% | -$21K |
|
1005
CONMED
CNMD
$1.47B
| $6.75M | 0.01% |
93,722
-4,181
| -4% | -$291K |
|
1006
Kohl's
KSS
$2.17B
| $6.73M | 0.01% |
323,858
-81,546
| -20% | -$1.57M |
|
1007
Fabrinet
FN
$20.1B
| $6.72M | 0.01% |
107,716
-7,951
| -7% | -$488K |
|
1008
ESCO Technologies
ESE
$7.89B
| $6.71M | 0.01% |
79,339
-5,355
| -6% | -$423K |
|
|
TCO
1009
DELISTED
Taubman Centers Inc.
TCO
| $6.7M | 0.01% |
177,418
+3,732
| +2% | +$153K |
|
|
B
1010
DELISTED
Barnes Group Inc.
B
| $6.69M | 0.01% |
169,182
-11,661
| -6% | -$448K |
|
1011
Chemours
CC
$2.4B
| $6.69M | 0.01% |
435,982
+1,421
| +0.3% | +$18K |
|
|
ATRI
1012
DELISTED
Atrion Corp
ATRI
| $6.69M | 0.01% |
10,496
+117
| +1% | +$76.5K |
|
1013
Hain Celestial
HAIN
$57.3M
| $6.68M | 0.01% |
212,106
-3,625
| -2% | -$105K |
|
|
MDC
1014
DELISTED
M.D.C. Holdings, Inc.
MDC
| $6.68M | 0.01% |
202,167
-15,297
| -7% | -$423K |
|
1015
Valmont Industries
VMI
$9.59B
| $6.67M | 0.01% |
58,711
+785
| +1% | +$87.1K |
|
1016
Fulton Financial
FULT
$4.66B
| $6.67M | 0.01% |
632,912
+53,142
| +9% | +$577K |
|
|
UNVR
1017
DELISTED
Univar Solutions Inc.
UNVR
| $6.66M | 0.01% |
395,010
+226,080
| +134% | +$3.24M |
|
1018
StoneCo
STNE
$2.58B
| $6.66M | 0.01% |
+171,797
| New | +$5.01M |
|
1019
Warner Bros
WBD
$66.8B
| $6.66M | 0.01% |
315,544
-3,803
| -1% | -$82.1K |
|
1020
NovoCure
NVCR
$1.9B
| $6.66M | 0.01% |
112,225
-9,170
| -8% | -$603K |
|
1021
FormFactor
FORM
$9.17B
| $6.65M | 0.01% |
226,579
-45,287
| -17% | -$1.12M |
|
1022
Liberty Media Series C
FWONK
$25.8B
| $6.64M | 0.01% |
216,673
+9,689
| +5% | +$288K |
|
1023
SouthState Bank Corp
SSB
$10.5B
| $6.64M | 0.01% |
139,242
+69,899
| +101% | +$3.65M |
|
1024
Teradata
TDC
$2.56B
| $6.63M | 0.01% |
318,948
+4,889
| +2% | +$106K |
|
|
BPMC
1025
DELISTED
Blueprint Medicines
BPMC
| $6.63M | 0.01% |
85,014
+9,004
| +12% | +$609K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2020 Portfolio in Review
As of Q2 2020, RhumbLine Advisers held 3,213 positions worth $59.9B, up 25% from $47.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers deployed $2B of net new capital in Q2 2020, opening 281 new positions and adding to 1,628 existing holdings. Its largest new stake was Otis Worldwide: 701,378 shares worth $39.9M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $12.9M trimmed.
- RhumbLine Advisers's largest Q2 2020 buy was Otis Worldwide: 701,378 shares worth $39.9M.
- RhumbLine Advisers added most to Amazon in Q2 2020, an estimated $134M increase.
- RhumbLine Advisers's biggest Q2 2020 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $12.9M.
- RhumbLine Advisers fully exited Allergan plc in Q2 2020, selling an estimated $92.9M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $59.9B portfolio in Q2 2020.
- RhumbLine Advisers opened 281 new positions and closed 147 in Q2 2020.
- RhumbLine Advisers's portfolio value rose 25% quarter-over-quarter to $59.9B.
Based on RhumbLine Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.